EUVIMEDEUVIMED entdecken
Crossref

DNA origami-based composite nanosandwich for iteratively potentiated chemo-immunotherapy

Mengyue Li, Hanxi Zhang, Peizheng Xiong, Yuhan He, Wanyi Zhou, Chunhui Wu, Xiaoling Liao, Wei Zhang, Hong Yang, Yiyao Liu

Journal of Controlled Release · 2025-03 · 379 · 452-465

DOI: 10.1016/j.jconrel.2025.01.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2025-03. Verfasst von Mengyue Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Sichuan Provincial People's Hospital, School of Life Science and Technology, University of Electronic Science and Technolo…. Hauptthemen laut MEDLINE: Doxorubicin, Oligodeoxyribonucleotides, B7-H1 Antigen, Aptamers, Nucleotide. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Sichuan Province Science and Technology Support Program, University of Electronic Science and Technology of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Developing effective nanoplatforms for chemo-immunotherapy to achieve enhanced tumor suppression and systemic antitumor immunity has recently received extensive attention. Herein, we formulated a multifunctional DNA sandwich nanodevice, DSWAC/siPD-L1, based on triangular DNA origami, to implement enhanced cancer chemo-immunotherapy. Taking advantage of the tumor-targeting ability of the AS1411 aptamer, DSWAC/siPD-L1 efficiently delivered doxorubicin (DOX), CpG, and siPD-L1 into tumor cells. Moreover, the sandwich cavity spatially protects siPD-L1 from degradation, and the featured design of the DNA/RNA duplex linkers ensures effective intracellular release of siPD-L1. The pH-responsive release of cytotoxic DOX induces apoptosis and initial mild immunogenic cell death of tumor cells, presenting antigens to enhance the maturation of dendritic cells (DCs) with the assistance of the immune adjuvant CpG, thereby activating cytotoxic T lymphocytes to amplify antitumor immunity. Simultaneously, siPD-L1 downregulated the endogenous expression of PD-L1 to inhibit adaptive tumor immune escape. DSWAC/siPD-L1 initiated the iterative revolution of the cancer-immunity cycle, leading to the inhibition of primary and metastatic tumors, as demonstrated by DC maturation and T-cell infiltration in established subcutaneous primary tumor model and metastatic lung tumor model. Furthermore, the superior antitumor effect of DSWAC/siPD-L1 resulted in approximately 91 % inhibition of primary tumor growth and 93 % prevention of lung metastasis. Collectively, this study describes a siPD-L1-based sandwich DNA nanodevice functionalized with AS1411/CpG for enhanced cancer chemo-immunotherapy, inspiring the creation of more innovative drug nanocarriers and the exploitation of novel cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinOligodeoxyribonucleotidesB7-H1 AntigenAptamers, NucleotideDNAAntibiotics, AntineoplasticNeoplasmsAnimalsImmunotherapyCell Line, TumorHumansMiceFemaleMice, Inbred C57BLDendritic CellsMice, Inbred BALB C

Stichwörter der Autor:innen

AS1411 aptamerChemo-immunotherapyCpGDNA origamisiPD-L1

Substanzen

DoxorubicinOligodeoxyribonucleotidesB7-H1 AntigenAptamers, NucleotideDNAAntibiotics, AntineoplasticAGRO 100

Autor:innen und Institutionen

  • Department of Orthopedics, Sichuan Provincial People's Hospital, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 610054, Sichuan, PR China.
  • TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, No. 39 Shi-er-qiao Road, Chengdu 610072, Sichuan, PR China.
  • Chongqing Engineering Laboratory of Nano/Micro Biomedical Detection Technology, Chongqing University of Science and Technology, Chongqing 401331, PR China. Electronic address: 2007099@cqust.edu.cn.
  • Department of Orthopedics, Sichuan Provincial People's Hospital, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 610054, Sichuan, PR China. Electronic address: zh…
  • Department of Orthopedics, Sichuan Provincial People's Hospital, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 610054, Sichuan, PR China. Electronic address: ya…
  • Department of Orthopedics, Sichuan Provincial People's Hospital, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 610054, Sichuan, PR China; TCM Regulating Metabol…

Förderung

  • Sichuan Province Science and Technology Support Program
  • University of Electronic Science and Technology of China
  • National Natural Science Foundation of China

Zitieren

APA

Li, M., Zhang, H., Xiong, P., He, Y., Zhou, W., Wu, C., Liao, X., Zhang, W., Yang, H., & Liu, Y. (2025). DNA origami-based composite nanosandwich for iteratively potentiated chemo-immunotherapy. Journal of Controlled Release, 379, 452-465. https://doi.org/10.1016/j.jconrel.2025.01.031

Vancouver

Li M, Zhang H, Xiong P, He Y, Zhou W, Wu C, et al. DNA origami-based composite nanosandwich for iteratively potentiated chemo-immunotherapy. Journal of Controlled Release. 2025;379:452-465. doi:10.1016/j.jconrel.2025.01.031

BibTeX
@article{Li2025,
  author = {Li, Mengyue and Zhang, Hanxi and Xiong, Peizheng and He, Yuhan and Zhou, Wanyi and Wu, Chunhui and Liao, Xiaoling and Zhang, Wei and Yang, Hong and Liu, Yiyao},
  title = {DNA origami-based composite nanosandwich for iteratively potentiated chemo-immunotherapy},
  journal = {Journal of Controlled Release},
  year = {2025},
  volume = {379},
  pages = {452--465},
  doi = {10.1016/j.jconrel.2025.01.031}
}
Kostenlos starten →